Follow The Filings

WY Weyerhaeuser

Weyerhaeuser earnings company data as of 3:58 PM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 29 Oct FFO 0.08 — —
Rev — — —

Insider trades

Open-market buys and sales by WY's executives, directors and 10% owners in the last 12 months, from their Form 4s

All WY insider trades
  • $722K bought by 3 insiders
  • $288K sold by 1 insider outside a trading plan
  • $2.1M sold by 1 insider under 10b5-1 plans
  1. James Calvin O'Rourke Director
    Buy
    $101K 4,000 shares at $25.35 +16% to stake
    Traded Feb 20 Filed Feb 20
    ↗
  2. Richard Beckwitt Director
    Buy
    $514K 20,000 shares at $25.70 +492% to stake
    Traded Feb 19 Filed Feb 20
    ↗
  3. Brian K Chaney Senior Vice President
    Sale
    $288K 11,157 shares at $25.82 11% of stake
    Traded Feb 3 Filed Feb 4
    ↗
  4. Sara Grootwassink Lewis Director
    Buy
    $106K 4,500 shares at $23.61 +21% to stake
    Traded Dec 17, 2025 Filed Dec 18, 2025
    ↗
  5. Devin W Stockfish CEO
    Planned sale
    $2.1M 90,162 shares at $23.33 8.1% of stake
    Traded Dec 15, 2025 Filed Dec 17, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 25 stock grants, 25 share withholdings for taxes, and 2 option exercises.

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.